Patrick D. Walsh

Filings by Patrick D. Walsh span 3 companies, the busiest being ANI Pharmaceuticals Inc, Avid Bioservices, Inc. and Lifecore Biomedical, Inc. \DE\. We count 21 filings; the first trade dates from 6 June 2018 and the latest from 3 March 2026.

The open-market side counts 8 purchases for €791k alongside 3 sales for €1.7M. On balance, insiders were net sellers of €925k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 9 share grants. So far in 2026, the count stands at no purchases and 1 sale.

In size, the median ticket on the buying side is €100k. Clusters matter here: 3 out of 8 purchases overlapped with buying by a colleague within 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

The latest filing, published on 3 March 2026, reports an open-market sale of €381k in ANI Pharmaceuticals Inc. The clock since the last published purchase (22 March 2022) now reads 1,692 days. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.